Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a ...

Aggressive forms of acute myeloid leukemia (AML) remain challenging to treat, especially in patients with FLT3-ITD mutations.

Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia ...

Acute myeloid leukemia, or AML, is a type of cancer that affects the bone marrow and blood. ... Treatment of children with acute myeloid leukemia (AML). (2020). https: ...

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that largely affects older adults. Discover the causes, risk factors, how it’s classified, and more information like on ...

Acute myeloid leukemia (AML) is among the most difficult to treat of the childhood cancers because of its disease heterogeneity, high relapse, and toxic mortality. 1,2 Therapeutic advances have ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

At just 11 years old, Aurelia Awa of West Oʻahu has already overcome more challenges than most face in a lifetime. Diagnosed ...

Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ( ...

Background: CBFA2T3::GLIS2-rearranged acute myeloid leukemia (AML) is a rare subtype of AML occurring exclusively in very young children and is associated with poor prognosis ( < 15% 5-year event-free ...